Koren-Michowitz, M., Gery, S., Tabayashi, T., Lin, D., Alvarez, R., Nagler, A., & Koeffler, H. P. (2013). SH2B3 (LNK) mutations from Myeloproliferative Neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Koren-Michowitz, Maya, Sigal Gery, Takayuki Tabayashi, Dechen Lin, Rocio Alvarez, Arnon Nagler, a H. Phillip Koeffler. SH2B3 (LNK) Mutations From Myeloproliferative Neoplasms Patients Have Mild Loss of Function against Wild Type JAK2 and JAK2 V617F. 2013.

Koren-Michowitz, Maya, et al. SH2B3 (LNK) Mutations From Myeloproliferative Neoplasms Patients Have Mild Loss of Function against Wild Type JAK2 and JAK2 V617F. 2013.